Puerperal group A streptococcal infection: Beyond semmelweis

Obstetrics and Gynecology

Volumn 123, Issue 4, 2014, Pages 874-882

  Anderson, Brenna L ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BRADYKININ; CLINDAMYCIN; ERYTHROMYCIN; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; M PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

AMPUTATION; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD ANALYSIS; BLOOD CULTURE; CEREBROSPINAL FLUID ANALYSIS; CHORIOAMNIONITIS; DEBRIDEMENT; ENDOMETRITIS; ENDOMETRIUM BIOPSY; FLUID RESUSCITATION; GENOTYPE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HYSTERECTOMY; INCIDENCE; INFECTION CONTROL; INNATE IMMUNITY; INTENSIVE CARE; LISTERIA MONOCYTOGENES; NONHUMAN; PENICILLIN ALLERGY; PERITONITIS; PLEURA FLUID; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PUERPERAL INFECTION; SEPTIC ABORTION; STREPTOCOCCUS PYOGENES; SYMPTOMATOLOGY; SYNOVIAL FLUID; TISSUE NECROSIS; TOXIC SHOCK SYNDROME;

DISEASE PROGRESSION; FEMALE; HISTORY, 19TH CENTURY; HUMANS; HYSTERECTOMY; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; PROGNOSIS; PUERPERAL INFECTION; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84898767306     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000175     Document Type: Article

References (44)

1. National Center for Immunization and Respiratory diseases: division of bacterial diseases. 2008 Available at: http://www.cdc.gov/ncidod/dbmd/ diseaseinfo/groupastreptococcal-t.htm. Retrieved September 30, 2013.
2. Rimawi BH, Soper DE, Eschenbach DA. Group A streptococcal infections in obstetrics and gynecology. Clin Obstet Gynecol 2012;55:864-74.
3. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007;45: 853-62.
4. Hamilton SM, Stevens DL, Bryant AE. Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome. Clin Infect Dis 2013;57:870-6.
5. Deutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C, Schrag S, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011;53:114-23.
6. Stefonek KR, Maerz LL, Nielsen MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol 2001;98:846-8.
7. Mead PB, Winn WC. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 2000; 8:217-9.
8. Mead PB. Streptococcal screening in obstetrics. Obstet Gynecol 2001;98:721-3.
9. Chuang I, Van Beneden C, Beall B, Schuchat A. Populationbased surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis 2002;35:665-70.
10. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996;335:547-54.
11. Sitkiewicz I, Green NM, Guo N, Bongiovanni AM, Witkin SS, Musser JM. Adaptation of group A Streptococcus to human amniotic fluid. PLoS One 2010;5:e9785.
12. Lapinsky SE. Obstetric infections. Crit Care Clin 2013;29:509-20.
13. Anderson BL, Mendez-Figueroa H, Dahlke JD, Raker C, Hillier SL, Cu-Uvin S. Pregnancy-induced changes in immune protection of the genital tract: defining normal. Am J Obstet Gynecol 2013;208:321.e1-9.
14. Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962;89:307-13.
15. Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, et al. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 2002;34:28-38.
16. Mandell G, Bennett J, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia (PA): Churchill Livingstone; 2010.
17. Morton A. Postpartum fever and shortness of breath. BMJ 2013;346:f391.
18. Ishiguro T, Matsushita H, Yanase T, Kurabayashi T, Yoshida S, Iinuma Y. Intrauterine fetal demise due to streptococcal toxic shock syndrome: a case report. Clin Exp Obstet Gynecol 2010; 37:226-8.
19. Sugiyama T, Kobayashi T, Nagao K, Hatada T, Wada H, Sagawa N. Group A streptococcal toxic shock syndrome with extremely aggressive course in the third trimester. J Obstet Gynaecol Res 2010;36:852-5.
20. Lee VH, Sulis C, Sayegh RA. Puerperal group A Streptococcus infection: a case report. J Reprod Med 2005;50:621-3.
21. Yagi H, Fukushima K, Satoh S, Nakashima Y, Nozaki M, Nakano H. Postpartum retroperitoneal fasciitis: a case report and review of literature. Am J Perinatol 2005;22:109-13.
22. Schummer W, Schummer C. Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome. Infect Dis Obstet Gynecol 2002;10:217-22.
23. Crum NF, Chun HM, Gaylord TG, Hale BR. Group A streptococcal toxic shock syndrome developing in the third trimester of pregnancy. Infect Dis Obstet Gynecol 2002;10:209-16.
24. GourlayM, Gutierrez C, Chong A, Robertson R. Group A streptococcal sepsis and ovarian vein thrombosis after an uncomplicated vaginal delivery. J Am Board Fam Pract 2001;14:375-80.
25. Anteby EY, Yagel S, Hanoch J, Shapiro M, Moses AE. Puerperal and intrapartum group A streptococcal infection. Infect Dis Obstet Gynecol 1999;7:276-82.
26. Jorup-Rönström C, Hofling M, Lundberg C, Holm S. Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature. Infection 1996;24:164-7.
27. Kiviat NB, Wølner-Hanssen P, Eschenbach DA, Wasserheit JN, Paavonen JA, Bell TA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14:167-75.
28. Sweet R, Gibbs R. Infectious diseases of the female genital tract. 4th ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2002.
29. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
30. Rivers E, Nguyen B, Havstad S, Ressler J,Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
31. Hamilton SM, Bayer CR, Stevens DL, Bryant AE. Effects of Selective and Nonselective Nonsteroidal Anti-inflammatory Drugs on Antibiotic Efficacy of Experimental Group A Streptococcal Myonecrosis. J Infect Dis 2013. [Epub ahead of print].
32. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952;13:389-99.
33. Brooks GF, Carroll CK, Butel JS, Morse SA, Mietzner TA. Jawetz, Melnick, and Adelberg's Medical Microbiology. 26th ed. New York (NY): McGraw Hill; 2013.
34. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-406.
35. Steer AC, Lamagni T, Curtis N, Carapetis Jr. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs 2012;72:1213-27.
36. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8.
37. Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A, et al.Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn Microbiol Infect Dis 2009;64:295-9.
38. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA; Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for antimicrobial chemotherapy. J Antimicrob Chemother 2004; 54:971-81.
39. Cremieux AC, Carbon C. Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. Antimicrob Agents Chemother 1992;36:2069-74.
40. Alejandria MM, Lansang MA, Dans LF, Mantaring JB III. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. The Cochrane Database of Systematic Reviews 2013:CD001090. doi: 10.1002/14651858.CD001090. pub2.
41. Shah SS, Hall M, Srivastava R, Subramony A, Levin JE. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009;49:1369-76.
42. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999;28:800-7.
43. Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37:333-40.
44. Daif JL, Levie M, Chudnoff S, Kaiser B, Shahabi S. Group a Streptococcus causing necrotizing fasciitis and toxic shock syndrome after medical termination of pregnancy. Obstet Gynecol 2009;113:504-6.